Our results show that STING and cGAS expression is often markedly reduced or abolished in SCLC cell lines and tumours, thus impairing the activity of the STING pathway and the activation of immune genes (Figs. 4–6). This evidence concerns the gene CGAS and small cell lung carcinoma.